Search research articles
Contact Us
Filters
Showing results (11-20 of 303) with videos related to
Page
of 31
Sort By:
The New England Journal of Medicine
|
December 2, 2020
Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care
Axel Grothey
The Lancet. Oncology
|
October 16, 2012
S-1 in colorectal cancer: a new standard of care?
Axel Grothey
Clinical Colorectal Cancer
|
May 6, 2005
Clinical management of oxaliplatin-associated neurotoxicity
Axel Grothey
Gastrointestinal Cancer Research : GCR
|
March 5, 2009
Improving the Odds for a Patient With Potentially Curable Stage IV Colorectal Cancer: A Question of Chemosensitivity
Axel Grothey
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2010
Adjuvant chemotherapy in colon cancer - is it worth it?
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
April 12, 2021
Refining the use and sequencing of third-line therapy in patients with metastatic colorectal cancer
Axel Grothey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2011
Does stage II colorectal cancer need to be redefined?
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
June 19, 2012
Regorafenib in metastatic colorectal cancer
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting
Axel Grothey
Statistical Methods in Medical Research
|
February 21, 2008
Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspective
Axel Grothey
Page
of 31
Search research articles
Search
Showing results (11-20 of 303) with videos related to
Sort By:
Page
of 31
The New England Journal of Medicine
|
December 2, 2020
Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care
Axel Grothey
The Lancet. Oncology
|
October 16, 2012
S-1 in colorectal cancer: a new standard of care?
Axel Grothey
Clinical Colorectal Cancer
|
May 6, 2005
Clinical management of oxaliplatin-associated neurotoxicity
Axel Grothey
Gastrointestinal Cancer Research : GCR
|
March 5, 2009
Improving the Odds for a Patient With Potentially Curable Stage IV Colorectal Cancer: A Question of Chemosensitivity
Axel Grothey
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2010
Adjuvant chemotherapy in colon cancer - is it worth it?
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
April 12, 2021
Refining the use and sequencing of third-line therapy in patients with metastatic colorectal cancer
Axel Grothey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2011
Does stage II colorectal cancer need to be redefined?
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
June 19, 2012
Regorafenib in metastatic colorectal cancer
Axel Grothey
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting
Axel Grothey
Statistical Methods in Medical Research
|
February 21, 2008
Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspective
Axel Grothey
Page
of 31